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The role of master regulators in gene regulatory networks
E. Herna´ndez-Lemus,1∗ K. Baca-Lo´pez,1 R. Lemus,1 R. Garc´ıa-Herrera1
Gene regulatory networks present a wide variety of dynamical responses to intrinsic and ex-
trinsic perturbations. Arguably, one of the most important of such coordinated responses
is the one of amplification cascades, in which activation of a few key-responsive tran-
scription factors (termed master regulators, MRs) lead to a large series of transcriptional
activation events. This is so since master regulators are transcription factors controlling
the expression of other transcription factor molecules and so on. MRs hold a central posi-
tion related to transcriptional dynamics and control of gene regulatory networks and are
often involved in complex feedback and feedforward loops inducing non-trivial dynamics.
Recent studies have pointed out to the myocyte enhancing factor 2C (MEF2C, also known
as MADS box transcription enhancer factor 2, polypeptide C) as being one of such master
regulators involved in the pathogenesis of primary breast cancer. In this work, we perform
an integrative genomic analysis of the transcriptional regulation activity of MEF2C and its
target genes to evaluate to what extent are these molecules inducing collective responses
leading to gene expression deregulation and carcinogenesis. We also analyzed a number
of induced dynamic responses, in particular those associated with transcriptional bursts,
and nonlinear cascading to evaluate the influence they may have in malignant phenotypes
and cancer.
I. Introduction: Transcriptional
master regulators
Phenotypic conditions in living cells are largely
determined by the interplay of a multitude of
molecules; in particular, genes and their protein
products. The coordinated behavior of such a
large number of players is often represented by
means of a gene regulatory network (GRN). In a
GRN, regulatory processes between genes, tran-
scription factors and other molecular components
are represented by nodes and links. One common
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way of inferring this gene regulatory networks is
by probabilistic analysis of whole genome gene
expression data [1, 2].
Specific, context-dependent analysis of regula-
tory activity of particular cellular phenotypes (say
tumor cells) may also be performed with the aid of
transcriptional interaction networks. Commonly,
such GRNs present a complex topology, often com-
pliant with a scale-free hierarchic nature, in which
a relatively small number of key players dominate
the function and dynamics of the network. Some of
these key players in GRNs are transcription factors
often known as master regulators (MRs). MRs are
deemed responsible for the control of the whole
regulatory program for cells under the associated
phenotype [3, 4]. Master regulators may, in-
deed, act over rather generalistic cellular processes
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[5], but also on specific cellular phenotypes [4, 6, 7].
For instance, it is known that the mTOR
molecule is active in concerting signals regulating
control growth, metabolism, and longevity. Mal-
function of mTOR complexes has been associated
with developmental abnormalities, autoimmune
diseases and cancer [5]. The main role of mTOR
seems to be the regulation of protein synthesis.
Detailed mechanisms remain unknown, but ribo-
some profiling seems to point out to translational
regulation and transcriptional activation activity.
Due to the multiplicity of mTOR signaling inter-
actions, this molecule acts as a master regulator
on a variety of phenotypes. More specific master
regulatory activity may be exemplified by cases
such as the one of VASH1 that has been identified
as a master-regulator of endothelial cell apoptosis
[4]; PAX5 is known to be a master regulator of
B-cell development also involved in neoplastic
processes in leukemogenesis [6] and the yeast
protein Gcn4Pp (that contains a conserved domain
cd12193 present in human JUN proto-oncogene)
that is triggered by starvation and stress signals
[7] and is an MR in the phenotypic response to
such stimuli. Due to the complex mechanisms
behind transcriptional regulation in eukaryotes,
identification of MRs is mostly based on the
(inferred or empirical) relationships between them
and their downstream RNA targets in the GRN.
In brief, MRs are transcription factor genes that
are located upstream in the genomic regulation
programme, hence they possess a high hierarchy
in the GRN. They are considered to be important
players behind the presence of (some) amplification
cascades in transcriptional regulatory networks,
and it has been hypothesized that they may
coordinate the dynamic transcriptional response
and phenotype (in the case of eukaryotes) of the
cells.
As it may be evident, MRs may have a big
impact on cancer-related phenotypes. This is so
since under genome instability conditions, the
uncontrolled synthesis of these molecules may
give rise to large amplification of transcriptional
cascades. In Ref. [11], the role that some molecules
(in particular, MEF2C) may have in processes
involving metabolic deregulation and MR activity
at the onset of primary breast cancer was studied.
The approach followed there involved the inference
of GRNs centered in a number of molecules
considered to be candidate MRs associated with
the breast cancer phenotypes at early stages (i.e.,
primary tumors). As it can be seen there, MEF2C
resulted a quite promissory molecule due to the
large number of (probabilistically inferred) targets
it possesses, but also due to the main biological
processes spanned by its targets.
i. A what if? scenario
Now, let us resort for a moment to a hypothetical
scenario: Imagine you have a eukaryotic cell with
deregulated metabolism (e.g., large local free energy
fluctuations) and a gene with transcription factor
activity that has a low activation energy threshold
(i.e., a relatively low absolute value for the free
energy of formation). Now imagine that this gene
is located (within the regulatory network) close
to energy transduction pathways and that it also
possesses a high hierarchy on the transcriptional
regulatory network as well as a relatively large
relaxation time.
To put it more clearly, the fact that a gene has
low activation energies means that the amount of
energy needed to activate its cellular biosynthesis
is minimum [8, 9], thus making this molecule more
prone to be produced by large free energy fluctu-
ations. The probability to have such large energy
fluctuations may be increased under abnormal
metabolism conditions [10, 11, 12] that may enable
events leading to transcriptional cascades.
In such scenario, large local free energy fluctu-
ations may randomly activate the transcription of
such a gene that in turn may be able to activate
long ranged transcriptional cascading before decay-
ing, thus affecting to a large degree the whole tran-
scriptional regulation programme of such cell. In-
deed, such a gene may be acting as a transcriptional
master regulator over that specific cell condition
(phenotype).
070011-2
Papers in Physics, vol. 7, art. 070011 (2015) / E. Herna´ndez-Lemus et al.
II. MEF2C as a master regulator
In Ref. [11], we discussed the evidence that may
point out to the MEF2C molecule as a candidate
master regulator for the transcriptional regulator
of human cells under the primary breast cancer
phenotype. Regarding this molecule, we know the
following: MEF2C is a transcription factor gene
located (in humans) in 5q14.3 on the minus strand.
This gene is 200,723 bp long and it encodes a 473-
aminoacid protein weighting 51.221 kDa. MEF2C
is a member of the Mef2 family that by means
of controlling gene expression (MEF2 molecules
are commonly acting as activator transcription
factors) is able to regulate cellular differentiation
and development [13]. MEF2 members are highly
versatile regulators since they contain both MEF2
and MADS-box DNA binding domains (see Fig.
1). The MADS-box serves as the minimal DNA-
binding domain, however an adjacent 29-amino
acid extension called the Mef2 domain is required
for high affinity DNA-binding and dimerization,
hence conferring a combinatorial DNA binding
repertoire through a number of transcription factor
recognition marks [14].
Figure 1: Poisson-Boltzmann visualization of the
MEF2C transcription factor protein showing the
action of both, mef2 and MADS-box DNA-binding
domains.
It is also known that the MEF2C protein
interacts with MAPK7 (involved in proliferation
and differentiation signaling) [15], EP300 (a
transcription factor that regulates cell growth and
cellular division) [16], TEAD1 (an enhancer TF
that co-regulates transcription with MEF2C), as
well as with a number of histone deacetylases,
most notably HDAC4, HDAC7, and HDAC9
[17, 18]. These protein-protein interactions, mostly
with other transcription factors, enhancers or
epigenomic regulators joined with their inherent
binding-site transcriptional activity made MEF2C
a quite functional and adaptable MR.
Aside from this, a non-equilibrium ther-
modynamics analysis of the coupling between
transcriptional regulation processes and metabolic
de-regulation in breast cancer cells has led to some
further evidence pointing out to MEF2C as an
MR that may be playing an important role in car-
cinogenic processes. This thermodynamic evidence
has been supplemented with information given by
probabilistically-inferred gene regulatory networks
centered around genes coordinating the coupling of
transcriptional control and metabolism. The GRN
was inferred by mutual information calculations
[19, 20] on a database of 1191 whole genome gene
expression experiments in biopsy captured tissue
from primary breast cancer patients and healthy
controls [11].
To further express that this behavior is related
to the coupling between transcriptional regulation
control and energy transduction pathways, let us
resort to Fig. 2. Figure 2 shows a gene ontology
network containing the biological processes statis-
tically enriched in a list of MEF2C regulated genes,
differentially expressed in a 1191-sample database
of whole genome gene expression experiments cu-
rated in our group [11]. In this figure, we may
see that statistically enriched biological processes
are shown as color-coded (white to red) according
to a p-value calculated from a hypergeometric urn
model test and corrected via the false discovery rate
(FDR) measure as it is explained elsewhere [11].
We can see that the two major families of biolog-
ical processes enriched are precisely those related
with energy-release metabolic pathways and tran-
scriptional regulation.
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Figure 2: Hierarchical network displaying statisti-
cal enriched Gene Ontology Biological Process en-
tries related with MEF2C cascading, we may see
that this evidence supports the hypothesis made in
Ref. [11] regarding a non-equilibrium coupling be-
tween metabolism and transcriptional regulation.
a. Transcription factor binding site analysis
In order to further validate the findings given
by non-equilibrium thermodynamics and prob-
abilistic regulatory networks, a computational
analysis of databases for DNA transcription
factor binding sites (TFBS) was performed. This
study included a systematic TFBS analysis for
MEF2C transcriptional influence by applying an
algorithm (MotEvo) [21] that incorporated -via
Bayesian optimization- information additional to
the sequence (physicochemical and electrostatic
features, motif conservation and phylogeny, ChIP
experiments, DeepCAGE sequencing, etc.). Such
analysis was performed with a stringent statistical
significance level (Response values > 1.5 corre-
sponding approx. to p* < 0.001) and showed that
genome-wide MEF2C is able to regulate 200 genes
directly.
The results of the TFBS analysis showed that
the set of MEF2C targets includes a number of
genes that participate in oncogenic processes such
as MRAS, IGFBP3, CTNND1, FOXN3, FOXP4,
HGMA2, MMP19, CORO1C, JAG1, ASXL1,
HSPB1, MB, RBL2, ZIC2, NR2F6, BCL-2, CBX7,
DNM2, MAFA, LGALS3BP, among others. Addi-
tionally, a number of MEF2C targets are in turn
TFs, which enlarges the range of transcriptional
influence of MEF2C (and help it to become an
MR).
In fact, second order transcriptional interactions
increase the range of influence of MEF2C to a GRN
composed of 1896 genes and 2156 regulatory inter-
actions (see Fig. 3) that was able to further in-
crease to 5852 genes and 18801 interactions up to
third order.
Figure 3: Gene regulatory network including up to
second order transcriptional interactions in MEF2C
targets. The network is composed of 1896 genes
and 2156 interactions.
III. Dynamics of master regulator
activity
Cells sometimes present bursts or pulses of activity
in their gene expression dynamic patterns. Burst-
ing may result from a series of stochastic biochem-
ical events and may be a source of large pheno-
typic heterogeneity of cell behavior and thus on
cellular conditions and disease. Noise in transcrip-
tional regulatory activity arises not only as a con-
sequence of randomness of biochemical processes
070011-4
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at the molecular level due to low molecule counts,
it also may arise from thermodynamic fluctuations
in cellular components and system level phenom-
ena due to cooperativity. Different levels of gene
regulation may be strongly coupled. When all
these elements are present, we say that the cells
are undergoing transcriptional bursts (TBs). Un-
der such dynamic scenario, protein production oc-
curs in pulses, each due to a single promoter or
transcription factor binding event. It is in these in-
stances that the phenomena can be related to the
presence of master regulators in the transcriptional
networks.
b. Bursting and synchronization
The non-linear behavior of GRN interactions can
be better understood in the light of periodic or
quasi-periodic expression levels for certain groups
of genes. By means of Power Spectral Density
(PSD) calculations we may gain greater insight in
such dynamic behavior. Power spectral density is
useful to describe the evolution of the variance that
in turn provides us with greater insight on the cor-
relation structure of the underlying regulatory pro-
cesses. The power spectral density of stochastic
quasi-stationary processes can be estimated when
considering non-linear time series analysis as fol-
lows.
Let us consider Γ as a series containing a time
course for intensity levels of gene expresion of a
single gene, then the associated power spectral den-
sity, I(ω) is given by:
I(ω) =
1
N
∣∣∣∣∣
N∑
t
Γ(t) exp(−i ωt)
∣∣∣∣∣
2
; ω ∈ [0, pi] (1)
Periodic behavior could be detected in a linear
model for Γ:
Γ(t) = β cos(ωt+ φ) + i (2)
β being a positive constant (amplitude),
ω ∈ [0, pi], φ is a uniformly distributed phase
shift (φ ∈ (−pi, pi]) and {i} is a sequence of
uncorrelated random variables with mean 0 and
variance σ2 independent of φ (i.e. a Gaussian
noise). Under this model, periodic behavior could
be traced-off by means of looking at significant
peaks in the power spectral density, either within
an ω-continuous process or more commonly with
ω taking discrete values 2pikN ; k = 0, 1, 2 . . . , [
N
2 ],
each of these discrete values is known as a Fourier
frequency.
If a time course Γ has hidden periodic compo-
nents, say with a given frequency ω?, then the
power spectral density will show a peak at ω?. If,
on the other hand, Γ is a random, aperiodic signal,
then the I(ω) Vs ω plot will be a (noisy) straight
line, mapping to β = 0 in the linear model as given
by Eq. 2. Then we may test the null hypothesis
β = 0 versus the data in order to determine signif-
icance . An early result from Fisher applies also to
finite time series, the so called g-statistic [22]:
g =
maxk I(ωk)∑N/2
k=1 I(ωk)
(3)
Values of g larger than expected lead to the rejec-
tion of the null hypothesis (i.e., random processes).
The exact g-distribution is given by:
P (g > x) = α(1− x)α−1 − α(α− 1)
2
(1− 2x)α−1
+ · · ·+ (−1)r α!
r!(α− r)! (1− rx)
α−1(4)
α = N/2 and r is the largest integer less than
1/x. So if the observed value of g is g?, then there is
a p-value P (g > g?) to evaluate the null hypothesis.
In Fig. 4, we can see the results of the appli-
cation of Fisher’s significance analysis (red line) to
the power spectral density profiles of two genes that
are regulated by MEF2C. We can see that both
genes present some significant peaks in the power
spectral density profiles, which means that some
quasi-periodicities are present (i.e., some frequency
bands are enriched). Further analyses have shown
that the peaks for different MEF2C targets are in-
deed heavily correlated in some instances. This is
related to a mechanism of functional synchroniza-
tion. For a more detailed description of such anal-
ysis, please see Ref. [23].
IV. Conclusions
As a consequence of the arguments just exposed
here, we have been able to reach some conclusions
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Figure 4: Power Spectral Density plots for the time course of two MEF2C-regulated genes (APOBEC3G
and BLNK) in a database of whole genome gene expression for primary breast cancer samples.
about the role that master regulators (in this
case MEF2C) may be playing in the function
and dynamics of gene regulatory networks for
particular phenotypes (in this case potentially
related to the onset of primary breast cancer).
In the first place, we may mention that MEF2C,
as a transcriptional master regulator, associated
with tumor phenotypes has a number of important
physico-chemical features: such as having a low
activation energy, and long decay times. MEF2C
also presents TFBSs of two quite general classes
(MADS and MEf2) which makes it a highly
versatile transcription factor molecule. Following
stringent TFBS analyses, MEF2C is potentially
involved in the regulation of up to 200 genes
directly, about 2000 at second order, and almost
6000 at third order (almost one fourth of the entire
human genome) and also a number of its target
genes are, in turn, transcription factors some of
them with global activity. However, we must stress
that MEF2C is not the only molecule responsible
for the regulatory programme of such molecules.
To what extent its coordinated action is able to
induce the phenotype in vivo is still something to
be determined by further experimental data.
In relation to the dynamics of biological pro-
cesses induced by MEF2C cascading, we have seen
that MEF2C targets present ‘stochastic bursting’
and such bursts in gene expression activity are
synchronized and long range correlated to a high
degree (i.e., Almost 1/f correlations). Dynamic
synchronization and long range correlation appear
to be functional biological phenomena. However,
ad hoc experimental testing is still in design.
With regards to the biological implications of
such findings (especially in the context of cancer
biology), we have observed that MEF2C may be
associated with tumor phenotypes (at least in
primary breast cancer, according to our results).
This is so because MEF2C has a number of direct
targets (and also many of the indirect ones) which
are molecules with known oncogenic activity. The
patterns of gene expression of MEF2C targets (even
for genes that are not differentially expressed) are
able to induce the phenotype consistently. Also,
statistical enrichment analyses, both for biological
processes and biochemical pathways, showed signif-
icant hits associated with cancer related categories.
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After this, all that one has to say is that a
lot of work is still to be done to understand the
complex mechanisms behind the Master Regula-
tory control of phenotypes (especially in disease-
related scenarios). Such investigations need to be
multidisciplinary in nature and must be anchored
in solid mathematical foundations compliant with
the tenets of the theory of complex systems, while
at the same time must be heavily relying on solid
biological knowledge. Comprehensive integrative
analyses under the systems biology paradigm will
surely hence be a must at the center of discussion
on these matters.
Acknowledgements - The authors gratefully ac-
knowledge support by grant 179431/2012 (CONA-
CYT), as well as federal funding from the National
Institute of Genomic Medicine (Me´xico).
[1] E Herna´ndez-Lemus, D Vela´zquez-Ferna´ndez,
J K Estrada-Gil, I Silva-Zolezzi, M F Herrera-
Herna´ndez, G Jime´nez-Sa´nchez, Information
theoretical methods to deconvolute genetic reg-
ulatory networks applied to thyroid neoplasms,
Physica A 388, 5057 (2009).
[2] A A Margolin, I Nemenman, K Basso, C Wig-
gins, G Stolovitzky, A Califano, ARACNe:
An algorithm for the reconstruction of gene
regulatory networks in a mammalian cellular
context, BMC Bioinformatics 7 (Suppl I), S7
(2006).
[3] K Basso, A A Margolin, G Stolovitzky, U
Klein, R Dalla-Favera, A Califano, Reverse en-
gineering of regulatory networks in human B
cells, Nat. Genet. 37 382 (2005).
[4] M Affara, D Sanders, H Araki, Y Tamada, B
J Dunmore, S Humphreys, S Imoto, C Savoie,
S Miyano, S Kuhara, D Jeffries, C Print, D
S Charnock-Jones, Vasohibin-1 is identified as
a master-regulator of endothelial cell apoptosis
using gene network analysis, BMC Genomics
14, 23 (2013).
[5] R Hosking, mTOR: The master regulator, Cell
149, 955 (2012).
[6] J. Medvedovic, A Ebert, H Tagoh, M Bus-
slinger, Pax5: A master regulator of b cell de-
velopment and leukemogenesis, Adv. Immunol.
111, 179 (2011).
[7] A G Hinnebusch, K Natarajan, Gcn4p, a mas-
ter regulator of gene expression, is controlled
at multiple levels by diverse signals of starva-
tion and stress, Eukaryot. Cell. 1, 22 (2002).
[8] S J Maerkl, S R Quake, A systems approach
to measuring the binding energy landscapes of
transcription factors, Science 315, 233 (2007).
[9] M Sawadogo, R G Roeder, Energy require-
ment for specific transcription initiation by the
human RNA polymerase II system, J. Biol.
Chem. 259, 5321 (1984).
[10] T Epstein, L Xu, R J Gillies, R A Gatenby,
Separation of metabolic supply and demand:
Aerobic glycolysis as a normal physiological re-
sponse to fluctuating energetic demands in the
membrane, Cancer Metabolism 2, 7 (2014).
[11] K Baca-Lo´pez, A Hidalgo-Miranda, M May-
orga, N Gutie´rrez-Na´jera, E Herna´ndez-
Lemus, The role of master regulators in the
metabolic/transcriptional coupling in breast
carcinomas, PLoS ONE 7, e42678 (2012).
[12] D A Tennant, R V Durn, E Gottlieb, Targeting
metabolic transformation for cancer therapy,
Nat. Rev. Cancer 10, 267 (2010).
[13] M J Potthoff, E N Olson, MEF2: A central
regulator of diverse developmental programs,
Development 134, 4131 (2007).
[14] J D Molkentin, E N Olson, Combinatorial con-
trol of muscle development by basic helix-loop-
helix and MADS-box transcription factors, P.
Natl. Acad. Sci. USA 93, 9366 (1996).
[15] C C Yang, O I Ornatsky, J C McDermott, T
F Cruz, C A Prody, Interaction of myocyte
enhancer factor 2 (MEF2) with a mitogen-
activated protein kinase, ERK5/BMK1, Nu-
cleic Acids Res. 26, 4771 (1998).
[16] V Sartorelli, J Huang, Y Hamamori, L Kedes,
Molecular mechanisms of myogenic coactiva-
tion by p300: Direct interaction with the acti-
vation domain of MyoD and with the MADS
070011-7
Papers in Physics, vol. 7, art. 070011 (2015) / E. Herna´ndez-Lemus et al.
box of MEF2C, Mol. Cell. Biol. 17, 1010
(1997).
[17] A H Wang, N R Bertos, M Vezmar, N Pel-
letier, M Crosato, H H Heng, J Th’ng, J Han,
X J Yang, DAC4, a human histone deacety-
lase related to yeast HDA1, is a transcriptional
corepressor, Mol. Cell. Biol. 19, 7816 (1999).
[18] A H Wang, X J Yang, Histone deacetylase 4
possesses intrinsic nuclear import and export
signals, Mol. Cell. Biol. 21, 5992 (2001).
[19] E Herna´ndez-Lemus, C Rangel-Escaren˜o, The
role of information theory in gene regulatory
network inference, In: Information theory:
New research, Eds. P Deloumeaux, J D Gorza-
lka, Mathematics Research Developments Se-
ries, Nova Publishing (2011).
[20] E Herna´ndez-Lemus, J M Siqueiros-Garc´ıa,
Information theoretical methods for complex
network structure reconstruction, Complex
Adap. Syst. Mod. 1, 8 (2013).
[21] P Arnold, I Erb, M Pachkov, N Molina, E
van Nimwegen, MotEvo: Integrated Bayesian
probabilistic methods for inferring regula-
tory sites and motifs on multiple alignments
of DNA sequences, Bioinformatics 28, 487
(2012).
[22] R A Fisher, Test of significance in harmonic
analysis, P. Roy. Soc. A 125, 54 (1929).
[23] E Herna´ndez-Lemus, K Baca-Lo´pez, Bursting
and synchronization in gene regulatory dynam-
ics, Rev. Mex. Fis. S 58, 63 (2012).
070011-8
